Patents by Inventor Michael DeGregorio

Michael DeGregorio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6037379
    Abstract: A method of lowering serum cholesterol levels comprising administering to a patient in need of such treatment an effective amount of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol, as well as pharmaceutical compositions useful in the method, is disclosed.
    Type: Grant
    Filed: October 8, 1998
    Date of Patent: March 14, 2000
    Assignee: Orion Corporation
    Inventors: Pirkko Harkonen, Tatu Miettinen, Eero Mantyla, Lauri Kangas, Michael DeGregorio
  • Patent number: 5912273
    Abstract: A pharmaceutical composition is provided for use in the prevention or treatment of osteoporosis comprising a therapeutically effective amount of a compound of formula (I) ##STR1## wherein R.sub.1 and R.sub.2 are independently H or OH, for the treatment or prevention of osteoporosis and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: September 25, 1997
    Date of Patent: June 15, 1999
    Assignee: Orion-Yhtyma Oy
    Inventors: Michael Degregorio, Valerie Wiebe, Lauri Kangas, Pirkko Harkonen, Kalervo Vaananen, Aire Laine
  • Patent number: 5750576
    Abstract: Compounds having formula (I) wherein R.sub.1 and R.sub.2 are independently H or OH, are useful in the treatment and prevention of osteoporosis. The compounds of formula (I) are devoid of significant antiestrogenic and estrogenic activity.
    Type: Grant
    Filed: April 1, 1997
    Date of Patent: May 12, 1998
    Assignee: Orion-Yhtyma Oy
    Inventors: Michael DeGregorio, Valerie Wiebe, Lauri Kangas, Pirkko Harkonen, Kalervo Vaananen, Aire Laine